CRISPR and Beyond, Wellcome Genome Campus, UK – Sep. 2 to 4, 2019

CRISPR and beyond – perturbations at scale to understand genomes

02 – 04 September 2019, Wellcome Genome Campus, UK

The rapid advances of CRISPR/Cas-based technologies and DNA synthesis now make it possible to modulate genomes with relative ease. These tools can help us understand how genetic variation impacts phenotype and answer important long-standing questions in biology that also impact human health, laying the foundations for precision medicine for heritable diseases and cancer treatment.
This conference will bring together biomedical researchers working on high throughput screening, genome engineering, and/or variant effect interpretation, to explore these advances.
Early Bird discount is available until 11 June 2019. A limited number of bursaries are available for PhD students to attend the meeting.
Please feel free to forward this message on to colleagues who may also have an interest in this conference.

Scientific sessions include:
  • Understanding impact of coding variants
  • Measuring consequences of non-coding variation
  • Screens for gene function in cells
  • Assaying gene function in organisms
  • Gene and drug function in disease
  • Interactions with genes, drugs, and environment
  • New technology for readouts and perturbations
John Doench
Broad Institute of MIT and Harvard, USA
Jolanda van Leeuwen
University of Lausanne, Lausanne, Switzerland
Leopold Parts
Wellcome Sanger Institute, UK
Lea Starita
University of Washington, USA
Brit Adamson
University of Princeton, USA

Brenda Andrews
University of Toronto, Canada

Michael Boutros
DKFZ Heidelberg, Germany

Ellen Bushell
Umea University, Sweden

Ulrich Elling
Institute of Molecular Biology, Austria

Douglas Fowler
Unversity of Washington, USA

Molly Gasperini
University of Washington, USA

Maya Ghoussaini
Open Targets, UK

Luke Gilbert

Emma Haapaniemi
University of Oslo, Norway

Ben Lehner
Centre for Genomic Regulation, Spain

James McFarland
Broad Institute, USA

Fritz Roth
University of Toronto, Canada

Jussi Taipale
University of Cambridge, UK

Sibylle Vonesch
EMBL, Germany

Yanli Wang
Institute of Biophysics CAS, China